产品中心Cell Resources
联系我们CONTACT US
- 400-999-210024小时服务热线
产品概述
名称 | NCI-H838 (人非小细胞肺癌细胞) (STR鉴定正确) |
别称 | H838; H-838; NCIH838 |
种属 | 人 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 | 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮 |
培养方案A(默认) |
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
|
推荐传代比例 | 1:3-1:4 |
推荐换液频率 | 2-3次/周 |
背景描述 | NCI-H838细胞于1984年建系,源于一位59岁患有非小细胞肺癌的白人男性吸烟者,从患者淋巴结转移灶分离而来。 |
年龄(性别) | 男性;59岁 |
组织来源 | 肺;源自转移部位:淋巴结 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 肺癌细胞 |
生物安全等级 | BSL-1 |
倍增时间 | ~55 hours |
保藏机构 | ATCC; CRL-5844 |
STR鉴定
-
STR位点信息
Amelogenin X CSF1PO 10 D2S1338 18 D3S1358 15 D5S818 11 D7S820 9 D8S1179 13,16 D13S317 8 D16S539 9,12 D18S51 12 D19S433 15.2 D21S11 32.2 FGA 22.2 PentaD 11 PentaE 5,12 TH01 7 TPOX 8,11 vWA 17 D6S1043 11 D12S391 21 D2S441 11 -
STR鉴定图
参考文献
-
Computational identification and experimental verification of a novel signature based on SARS-CoV-2–related genes for predicting prognosis, immune microenvironment and therapeutic strategies in lung adenocarcinoma patients (2024-03-26)
作者:Yuzhi Wang:1.Department of Laboratory Medicine, Deyang People's Hospital, Deyang, Sichuan, China. ; 2.Pathogenic Microbiology and Clinical Immunology Key Laboratory of Deyang City, Deyang People's Hospital, Deyang, Sichuan, China. ; Yunfei Xu:1.Department of Laboratory Medicine, Chengdu Women's and Children's Central Hospital, Chengdu, Sichuan, China. ; Yuqin Deng:1.Department of Cardiology, Jianyang People's Hospital, Jianyang, China. ; Liqiong Yang:1.Department of Laboratory Medicine, Deyang People's Hospital, Deyang, Sichuan, China. ; 2.Pathogenic Microbiology and Clinical Immunology Key Laboratory of Deyang City, Deyang People's Hospital, Deyang, Sichuan, China. ; Dengchao Wang:1.Department of Laboratory Medicine, Deyang People's Hospital, Deyang, Sichuan, China. ; 2.Pathogenic Microbiology and Clinical Immunology Key Laboratory of Deyang City, Deyang People's Hospital, Deyang, Sichuan, China. ; Zhizhen Yang:1.College of Medical Technology, Chengdu University of Traditional Ch
期刊:Computational identification and experimental verification of a novel signature based on SARS-CoV-2–related genes for predicting prognosis, immune microenvironment and therapeutic strategies in lung adenocarcinoma patients
DOI:10.3389/fimmu.2024.1366928
影响因子 :7.3
引用产品: A549 [A-549] 细胞 , NCI-H838 细胞
-
Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma (2023-08-16)
作者:Yu Zhang:1.Department of Pulmonary and Critical Care Medicine, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, 250021, China. ; Tianyi Zhang:1.Research Center of Translational Medicine, Jinan Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China. ; Yingdong Zhao:1.Liaocheng Third People's Hospital, Liaocheng, Shandong, 252000, China. ; Hongdi Wu:1.Department of Fundamental, Air Force Communications NCO Academy, Dalian, Liaoning, 116000, China. ; Qiang Zhen:1.College of Pharmacy, Shandong First Medical University, Jinan, Shandong, 250021, China. ; Suwei Zhu:1.Department of Critical-Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China. 1446245184@qq.com. ; Shaoshuai Hou:1.Department of Pharmacy, Tengzhou Central People's Hospital, Tengzhou, Shandong, 277500, China. 1760106002@qq.com. ;
期刊:Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma
DOI:10.1186/s12885-023-11221-6
影响因子 :3.8
引用产品: NCI-H1299 细胞 , A549 [A-549] 细胞 , NCI-H838 细胞 , NCI-H1975 细胞
-
Sevoflurane Confers Protection Against the Malignant Phenotypes of Lung Cancer Cells via the microRNA-153-3p/HIF1α/KDM2B Axis (2023-12-21)
作者:Kai Xiong:1.Department of Anesthesiology, The 4th Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330003, Jiangxi, People's Republic of China. ; Zhiying Wu:1.Department of Oncology, The 334 Affiliated Hospital of Nanchang University, No.97, Xinxiqiao East Second Road, Qingyunpu District, Nanchang, 330024, Jiangxi, People's Republic of China. wuzhiying198204@163.com. ;
期刊:Sevoflurane Confers Protection Against the Malignant Phenotypes of Lung Cancer Cells via the microRNA-153-3p/HIF1α/KDM2B Axis
DOI:10.1007/s10528-023-10607-2
影响因子 :2.4
引用产品: NCI-H838 细胞
FAQs
Q:{{item.question}}
A:
产品资料
识别码示意图